Globally, in 2017 35 million people were living with HIV (PLHIV) and 257 million had chronic
HBV infection (HBsAg positive). The extent of HIV‐HBsAg co‐infection is unknown. We …

Elimination of hepatitis C virus (HCV) without the need for medical intervention, known as
spontaneous clearance (SC), occurs at a significantly lower rate than in the case of hepatitis …

New advances in the treatment of hepatitis C provide high levels of sustained viral response
but their expense limits availability in publicly funded health systems. The aim of this review …

Coinfections of hepatitis C virus (HCV) and/or hepatitis B virus (HBV) with human
immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) are associated …

This study was aimed at determining the prevalence estimate and association of transfusion-
transmitted infections (TTIs) with ABO and Rh blood groups among blood donors at the King …

Background: Estimates of the prevalence and disease burden of HIV/HCV coinfection in the
Asia Pacific Region are uncertain. Methods: A systematic review of indexed (PubMed …

Hepatitis C viral infection (HCV) represents a significant public health burden, chronically
infecting between 2.7 and 4.1 million people in the United States civilian population 1, 2 and …

Cancer is a leading cause of death among people living with HIV/AIDS (PLWHA). We
conducted a systematic review and meta-analysis to evaluate prevalence of cancer risk …

The study objective was to retrospectively analyze the metabolic variables derived from 18 F-
fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography …

Abstract Background and Aim Hepatitis B, C, and D virus (HBV, HCV, and HDV) infections
are known to be prevalent in injection drug users (IDUs); however, the relationship between …